🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wylie K. Watlington

Duke University

ORCID: 0009-0004-5335-6518

Also affiliated with Duke Medical Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of transcriptional cyclin-dependent kinases, CDK12/13, as a treatment for colorectal cancer with CDK12 upregulation.”.

Inhibition of transcriptional cyclin-dependent kinases, CDK12/13, as a treatment for colorectal cancer with CDK12 upregulation.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e15722

N/A

0.165DataRank · unranked

2 citations

Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi Olawuni, Gabrielle Rupprecht +6 more

Effects and Eradication of Mycoplasma Contamination on Patient-derived Colorectal Cancer Organoid Cultures

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0109

N/A

0DataRank · unranked

6 citations

Wylie K. Watlington, John B. Mantyh, Gabrielle Rupprecht, David S. Hsu, Divya L. Dayanidhi

Dual targeting of conserved cell cycle and transcription programs in advanced colorectal cancer by fadraciclib

Evolution Medicine and Public Health(2025)10.1093/emph/eoaf021

N/A

0DataRank · unranked

0 citations

Wylie K. Watlington, Divya L. Dayanidhi, John B. Mantyh, Gabrielle Rupprecht, Shannon J. McCall +4 more